Patents by Inventor Evelyne Chesne

Evelyne Chesne has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF TREATING DISEASES ASSOCIATED WITH ILC2 CELLS
    Publication number: 20190358264
    Abstract: Provided herein are compositions including compounds and/or cells for treating a disease associated with Group 2 innate lymphoid cells (ILC2s), and methods of treatment.
    Type: Application
    Filed: March 29, 2017
    Publication date: November 28, 2019
    Applicant: Limm Therapeutics, SA
    Inventors: José Henrique Veiga Fernandes, Vânia Rita De Faria Cardoso, Julie Michelle Evelyne Chesné
  • CETP MODULATOR FOR USE IN THE TREATEMENT OF EYE DISEASE
    Publication number: 20190224147
    Abstract: The invention relates CETP modulator which is useful in the prevention, treatment, delaying progression and/or reduction of eye diseases.
    Type: Application
    Filed: April 3, 2019
    Publication date: July 25, 2019
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Evelyne Chesne, Eric J. Niesor
  • USE OF N-(4-TERT-BUTYLBENZYL)-3-CHLORO-N-[2-(4-CHLORO-3-ETHYL-PHENYL)-ETHYL]-2-FLUORO-5-TRIFLUOROMETHYL-BENZAMIDE FOR THE TREATMENT OF EYE DISEASES
    Publication number: 20170035708
    Abstract: The present invention relates N-(4-tert-Butyl-benzyl)-3-chloro-N-[2-(4-chloro-3-ethyl-phenyl)-ethyl]-2-fluoro-5-trifluoromethyl-benz-amide which is useful in the prevention, treatment, delaying progression and/or reduction of eye diseases, in particular wherein the eye diseases are intraocular neovascular diseases and its method of preventing, retarding and ameliorating eye diseases, in particular intraocular neovascular diseases.
    Type: Application
    Filed: April 6, 2016
    Publication date: February 9, 2017
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Evelyne Chesne, Guido Hartmann
  • CETP MODULATOR FOR USE IN THE TREATEMENT OF EYE DISEASE
    Publication number: 20160287537
    Abstract: The present invention relates CETP modulator which is useful in the prevention, treatment, delaying progression and/or reduction of eye diseases.
    Type: Application
    Filed: June 7, 2016
    Publication date: October 6, 2016
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Evelyne Chesne, Eric J. Niesor